Treatment of nonresectable cancer of the lung with hydroxyurea (NSC-32065) given intermittently.
D000284:Administration, Oral; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D006918:Hydroxyurea / Q000008:administration & dosage / Q000627:therapeutic use* / Q000633:toxicity; D007275:Injections, Intravenous; D008175:Lung Neoplasms / Q000188:drug therapy*
D003520:Cyclophosphamide; D006918:Hydroxyurea